You can receive insights into any symbol that we track. You'll see relevant statistics, signals, pricing data, etc.
Business Units or Product Lines |
Bio-Rad Laboratories operates through two main business segments: Life Science and Clinical Diagnostics. The Life Science segment includes products for the research community, including reagents, instruments, and software for DNA amplification, gene sequencing, and protein quantification. The Clinical Diagnostics segment includes a diverse range of devices, software, and consumables for clinical testing in hospitals and laboratories. |
Business Models for Each Product Line |
The Life Science segment generates revenue through the sale of high-margin reagents and consumables, as well as instruments that require ongoing customer support and service contracts. Expenses mainly include R&D, production, and distribution costs. The Clinical Diagnostics segment earns revenue from the ongoing sale of diagnostic testing devices and consumables, with significant investment required in regulatory compliance, production, and quality control. |
Future Opportunities for Growth |
Bio-Rad sees growth opportunities in the expanding global healthcare market, increasing demand for personalized medicine, and advancements in genomics and proteomics. Strategic acquisitions and development of innovative technologies also present growth potential. |
Potential Major Risks |
Risks include regulatory changes, increased competition, potential product recalls, and reliance on government healthcare spending. Additionally, foreign exchange fluctuations and supply chain disruptions could impact operational and financial performance. |
Learn More about Bio-Rad Laboratories, Inc.:
Company Insights by Algobear (ChatGPT);
Tell me more about Bio-Rad Laboratories, Inc.'s latest earnings (BIO:Nyse)
Who are some of Bio-Rad Laboratories, Inc.'s competitors? (BIO:Nyse)
Are analysts bullish on Bio-Rad Laboratories, Inc.? Please show it in a table format. (BIO:Nyse)
Also read:
https://finance.yahoo.com/BIO/profile
Market Cap-Display | Market Cap-Actual | Market Cap | Enterprise Value-Display | Enterprise Value-Actual | Enterprise Value | Forward P/E | PEG Ratio (5yr expected) | Price/Sales | Price/Book | Enterprise Value/Revenue | Profit Margin | Operating Margin | Return on Assets | Return on Equity | Revenue-Display | Revenue-Actual | Revenue | Quarterly Revenue Growth | EBITDA-Display | EBITDA-Actual | EBITDA | Diluted EPS | Total Cash-Display | Total Cash-Actual | Total Cash | Total Debt-Display | Total Debt-Actual | Total Debt | Total Debt/Equity | Current Ratio | Operating Cash Flow-Display | Operating Cash Flow-Actual | Operating Cash Flow | Levered Free Cash Flow-Display | Levered Free Cash Flow-Actual | Levered Free Cash Flow | % Held by Insiders | % Held by Institutions |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6.69 B | 6690000000.0 | 6.69 | 6.4 B | 6400000000.0 | 6.4 | 25.91 | 1.19 | 2.62 | 1.02 | 2.49 | -71.86% | 8.68% | 1.55% | -24.09% | 2.57 B | 2570000000.0 | 2.57 | -2.00% | 420.0 mn | 420600000.0 | 0.42 | -65.36 | 1.66 B | 1660000000.0 | 1.66 | 1.37 B | 1370000000.0 | 1.37 | 0.20929999999999999 | 6.48 | 460.0 mn | 455200000.0 | 0.46 | 180.0 mn | 180860000.0 | 0.18 | 15.58% | 84.32% |
source:https://finance.yahoo.com/BIO/key-statistics
source:https://www.google.com/finance/quote/BIO:NYSE
source:https://finance.yahoo.com/BIO/analysis
source:https://finance.yahoo.com/BIO/fair-value
source:https://www.nasdaq.com/market-activity/stocks/BIO/price-earnings-peg-ratios
Key | Weighted | 5D | 1M | 3M | 6M | 1Y | 3Y | 10Y |
---|---|---|---|---|---|---|---|---|
Upside % (high) | 28.64% | 7.16% (260) | 7.16% (260) | 54.02% (373.69) | 59.91% (387.99) | 59.91% (387.99) | 136.9% (574.8) | 243.2% (832.7) |
Downside % (low) | 9.24% | 4.16% (232.53) | 11.23% (215.38) | 11.23% (215.38) | 11.23% (215.38) | 11.23% (215.38) | 11.23% (215.38) | 49.71% (122.03) |
Spread % | 19.4% | 3.0% | -4.07% | 42.79% | 48.68% | 48.68% | 125.67% | 193.49% |
BIO's price used for computing the stats is 242.63 as on date
Key | Today | 5D | 2W | 1M | 3M | 6M | 1Y | 3Y | 10Y |
---|---|---|---|---|---|---|---|---|---|
Last Price-Trend PrevClose | -2.85% | -1.05% | -2.62% | -5.46% | -29.14% | -27.99% | -13.39% | -56.4% | 77.79% |
Last Price | 242.63 | 242.63 | 242.63 | 242.63 | 242.63 | 242.63 | 242.63 | 242.63 | 242.63 |
Trend-Previous Close | 249.74 | 245.21 | 249.17 | 256.65 | 342.41 | 336.92 | 280.13 | 556.46 | 136.47 |
BIO's symbol cumulative return percent is computed basis data from date
5D | 2W | 1M | 3M | 6M | 1Y | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5D window |
5D Opportunity:
returns:
-1.05%
(-5.9%),
p.close: 245.21
entry:
230.75,
exit:
235.55,
min.ret:
2.08%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
returns:
-1.05%
(-6.84%),
p.close: 245.21
entry:
228.45,
exit:
232.67,
min.ret:
1.85%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
returns:
-1.05%
(-8.27%),
p.close: 245.21
entry:
224.93,
exit:
223.43,
min.ret:
-0.67%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
returns:
-1.05%
(-10.76%),
p.close: 245.21
entry:
218.81,
exit:
219.11,
min.ret:
0.13%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
returns:
-1.05%
(-9.71%),
p.close: 245.21
entry:
221.41,
exit:
221.46,
min.ret:
0.02%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
returns:
-1.05%
(-7.96%),
p.close: 245.21
entry:
225.7,
exit:
225.43,
min.ret:
-0.12%
Using: 5D trend, 0 Days Left
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2W window |
2W Opportunity:
returns:
-2.62%
(-12.11%),
p.close: 249.17
entry:
219.0,
exit:
237.17,
min.ret:
8.3%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
returns:
-2.62%
(-12.35%),
p.close: 249.17
entry:
218.39,
exit:
222.01,
min.ret:
1.66%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
returns:
-2.62%
(-17.06%),
p.close: 249.17
entry:
206.67,
exit:
207.54,
min.ret:
0.42%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
returns:
-2.62%
(-14.78%),
p.close: 249.17
entry:
212.33,
exit:
214.9,
min.ret:
1.21%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
returns:
-2.62%
(-12.19%),
p.close: 249.17
entry:
218.79,
exit:
221.2,
min.ret:
1.1%
Using: 2W trend, 0 Days Left
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1M window |
1M Opportunity:
returns:
-5.46%
(-15.75%),
p.close: 256.65
entry:
216.23,
exit:
220.46,
min.ret:
1.95%
Using: 1M trend, 0 Days Left
|
1M Opportunity:
returns:
-5.46%
(-27.48%),
p.close: 256.65
entry:
186.13,
exit:
186.19,
min.ret:
0.03%
Using: 1M trend, 0 Days Left
|
1M Opportunity:
returns:
-5.46%
(-22.08%),
p.close: 256.65
entry:
199.98,
exit:
204.21,
min.ret:
2.12%
Using: 1M trend, 0 Days Left
|
1M Opportunity:
returns:
-5.46%
(-19.02%),
p.close: 256.65
entry:
207.83,
exit:
211.43,
min.ret:
1.73%
Using: 1M trend, 0 Days Left
|
BIO's symbol current price is 242.63 (-2.85%) as on . Yesterday's close was 249.74. It's return velocities are computed basis data from date .